Omeros Net Profit Margin 2010-2023 | OMER
Omeros net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Omeros Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2020-06-30 | $0.07B | $-0.11B | -157.35% |
| 2020-03-31 | $0.08B | $-0.09B | -108.64% |
| 2019-09-30 | $0.10B | $-0.08B | -77.23% |
| 2019-06-30 | $0.08B | $-0.10B | -132.89% |
| 2019-03-31 | $0.05B | $-0.12B | -237.25% |
| 2018-12-31 | $0.03B | $-0.13B | -409.68% |
| 2018-09-30 | $0.02B | $-0.12B | -521.74% |
| 2018-06-30 | $0.04B | $-0.09B | -220.00% |
| 2018-03-31 | $0.06B | $-0.07B | -123.64% |
| 2017-12-31 | $0.07B | $-0.05B | -81.54% |
| 2017-09-30 | $0.06B | $-0.06B | -87.50% |
| 2017-06-30 | $0.05B | $-0.06B | -118.87% |
| 2017-03-31 | $0.05B | $-0.06B | -134.78% |
| 2016-12-31 | $0.04B | $-0.07B | -165.85% |
| 2016-09-30 | $0.04B | $-0.07B | -194.29% |
| 2016-06-30 | $0.03B | $-0.07B | -274.07% |
| 2016-03-31 | $0.02B | $-0.08B | -390.00% |
| 2015-12-31 | $0.01B | $-0.08B | -584.62% |
| 2015-09-30 | $0.01B | $-0.08B | -1283.33% |
| 2015-06-30 | $0.00B | $-0.08B | -2500.00% |
| 2015-03-31 | $0.00B | $-0.08B | inf% |
| 2014-12-31 | $0.00B | $-0.07B | inf% |
| 2014-09-30 | $0.00B | $-0.06B | inf% |
| 2014-06-30 | $0.00B | $-0.05B | inf% |
| 2014-03-31 | $0.00B | $-0.05B | inf% |
| 2013-12-31 | $0.00B | $-0.04B | -4000.00% |
| 2013-09-30 | $0.00B | $-0.05B | -1533.33% |
| 2013-06-30 | $0.00B | $-0.05B | -1125.00% |
| 2013-03-31 | $0.01B | $-0.04B | -666.67% |
| 2012-12-31 | $0.01B | $-0.04B | -650.00% |
| 2012-09-30 | $0.01B | $-0.04B | -820.00% |
| 2012-06-30 | $0.01B | $-0.04B | -700.00% |
| 2012-03-31 | $0.00B | $-0.03B | -775.00% |
| 2011-12-31 | $0.00B | $-0.03B | -725.00% |
| 2011-09-30 | $0.00B | $-0.03B | -650.00% |
| 2011-06-30 | $0.00B | $-0.03B | -900.00% |
| 2011-03-31 | $0.00B | $-0.03B | -1500.00% |
| 2010-12-31 | $0.00B | $-0.03B | -3000.00% |
| 2010-09-30 | $0.00B | $-0.03B | inf% |
| 2010-06-30 | $0.00B | $-0.03B | inf% |
| 2010-03-31 | $0.00B | $-0.02B | inf% |
| 2009-12-31 | $0.00B | $-0.02B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.196B | $0.000B |
| Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.944B | 24.52 |
| Stryker (SYK) | United States | $129.029B | 31.99 |
| Medtronic (MDT) | Ireland | $106.531B | 15.08 |
| Boston Scientific (BSX) | United States | $98.941B | 32.90 |
| EssilorLuxottica (ESLOY) | France | $97.450B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.229B | 0.00 |
| Haleon (HLN) | United Kingdom | $36.803B | 28.79 |
| ResMed (RMD) | United States | $27.225B | 27.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.477B | 16.40 |
| Terumo (TRUMY) | Japan | $24.641B | 34.80 |
| Baxter (BAX) | United States | $20.333B | 14.83 |
| Koninklijke Philips (PHG) | Netherlands | $18.954B | 15.12 |
| Insulet (PODD) | United States | $12.180B | 63.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.404B | 0.00 |
| Demant (WILYY) | Denmark | $10.167B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.567B | 25.52 |
| BellRing Brands (BRBR) | United States | $7.140B | 38.39 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.130B | 10.66 |
| Perrigo (PRGO) | Ireland | $4.083B | 11.68 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.383B | 15.99 |
| Envista Holdings (NVST) | United States | $3.289B | 12.51 |
| QuidelOrtho (QDEL) | United States | $2.772B | 10.06 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| Neogen (NEOG) | United States | $2.601B | 25.02 |
| ICU Medical (ICUI) | United States | $2.366B | 17.66 |
| TG Therapeutics (TGTX) | United States | $2.173B | 703.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.039B | 0.00 |
| Owens & Minor (OMI) | United States | $1.914B | 18.38 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.644B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.505B | 46.88 |
| InMode (INMD) | Israel | $1.486B | 7.69 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.74 |
| AdaptHealth (AHCO) | United States | $1.313B | 9.88 |
| Warby Parker (WRBY) | United States | $1.282B | 0.00 |
| AtriCure (ATRC) | United States | $1.108B | 0.00 |
| MacroGenics (MGNX) | United States | $1.060B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.710B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.706B | 15.26 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| Evolus (EOLS) | United States | $0.689B | 0.00 |
| Quanterix (QTRX) | United States | $0.653B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.636B | 0.00 |
| Valneva SE (VALN) | France | $0.590B | 0.00 |
| Jin Medical (ZJYL) | China | $0.541B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.535B | 11.59 |
| TerrAscend (TSNDF) | Canada | $0.524B | 0.00 |
| PetIQ (PETQ) | United States | $0.476B | 17.78 |
| Biote (BTMD) | United States | $0.439B | 4.18 |
| ZimVie (ZIMV) | United States | $0.428B | 26.23 |
| OraSure Technologies (OSUR) | United States | $0.414B | 6.85 |
| Zynex (ZYXI) | United States | $0.385B | 44.30 |
| Surmodics (SRDX) | United States | $0.376B | 40.65 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 31.31 |
| Cerus (CERS) | United States | $0.314B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.245B | 14.95 |
| Veru (VERU) | United States | $0.224B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.185B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.182B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.161B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 21.52 |
| Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.114B | 0.00 |
| InterCure (INCR) | Israel | $0.112B | 18.85 |
| Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.106B | 9.15 |
| Safety Shot (SHOT) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| MariMed (MRMD) | United States | $0.098B | 0.00 |
| Brainsway (BWAY) | Israel | $0.088B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.070B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.068B | 4.41 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 13.75 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.73 |
| ProSomnus (OSA) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |